You are here: Industry Insights > Sosei Heptares

News List

Sosei Heptares to Receive Milestone Payment from Formosa Pharmaceuticals americanpharmaceuticalreview
July 22, 2019
osei Group announces Formosa Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for APP13007 to commence a first-in-human (FIH) clinical trial in the United States.
Sosei Heptares and Genentech enter GPCR target alliance pharmaceutical-technology
July 18, 2019
Japanese biopharmaceutical group Sosei Heptares has partnered with Roche subsidiary Genentech for the discovery and development of drugs that modulate G protein-coupled receptor (GPCR) targets.
Sosei Heptares teams up with Genentech for multi-target R&D biospectrumasia
July 17, 2019
Collaboration aims to discover and develop novel medicines that modulate G protein-coupled receptor (GPCR) targets across a range of diseases
Sosei Heptares, Genentech Announces Research, License Agreement americanpharmaceuticalreview
July 17, 2019
Sosei Group has entered into a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and develop novel medicines (new small molecules and/or biologics) that modulate G protein-coupled receptor (
Sosei Heptares to get $3m Pfizer milestone payment pharmatimes
June 11, 2019
Sosei Heptares has announced that it is to receive a new $3 million milestone payment from its strategic alliance partner Pfizer, as it advances a second candidate from the GPCR collaboration for clinical development.

Previous page 1 2 Next page